1-8 of 8
Ping-Ying Pan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2006: A novel macromolecular platinum drug with potent efficacy to overcome cross-resistance in cancer therapy

Yongbin Liu, Dongfang Yu, Junhua Mai, Ping-Ying Pan, Shu-Hsia Chen, Haifa Shen
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2006.
https://doi.org/10.1158/1538-7445.AM2023-2006
Published: 04 April 2023
View article titled, Abstract 2006: A novel macromolecular platinum drug with potent efficacy to overcome cross-resistance in cancer therapy
Journal Articles

Abstract CT175: Targeting inducible nitric oxide in a first-in-class phase 1/2 trial in triple-negative breast cancer patients diminishes M2 macrophage polarization and led to a robust clinical response

Andrew W. Chung, Kartik Anand, Polly Niravath, Nakul Gupta, Luz A. Venta, Mary R. Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, Qiuying Chen, Nabeel Attarwala, John Kuhn, Tejal A. Patel, Angel Rodriguez, Anna Belcheva, Jorge Darcourt, Joe E. Ensor, Eric Bernicker, Ping-Ying Pan, Virginia Kaklamani, Shu-Hsia Chen, Jenny C. Chang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT175.
https://doi.org/10.1158/1538-7445.AM2021-CT175
Published: 01 July 2021
View article titled, Abstract CT175: Targeting inducible nitric oxide in a first-in-class phase 1/2 trial in triple-negative breast cancer patients diminishes M2 macrophage polarization and led to a robust clinical response
Journal Articles

Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy

Samuel Eisenstein, Brian A. Coakley, Karen Briley-Saebo, Ge Ma, Hui-ming Chen, Marcia Meseck, Stephen Ward, Celia Divino, Savio Woo, Shu-Hsia Chen, Ping-Ying Pan
Journal: Cancer Research
Cancer Res (2013) 73 (16): 5003–5015.
https://doi.org/10.1158/0008-5472.CAN-12-1597
Published: 13 August 2013
View article titled, Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
Open the PDF for Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy in another window
Includes: Supplementary data
Journal Articles

Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer

Ping-Ying Pan, Ge Ma, Kaare J. Weber, Junko Ozao-Choy, George Wang, Bingjiao Yin, Celia M. Divino, Shu-Hsia Chen
Journal: Cancer Research
Cancer Res (2010) 70 (1): 99–108.
https://doi.org/10.1158/0008-5472.CAN-09-1882
Published: 04 January 2010
View article titled, Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Open the PDF for Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer in another window
Includes: Supplementary data
Journal Articles

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

Junko Ozao-Choy, Ge Ma, Johnny Kao, George X. Wang, Marcia Meseck, Max Sung, Myron Schwartz, Celia M. Divino, Ping-Ying Pan, Shu-Hsia Chen
Journal: Cancer Research
Cancer Res (2009) 69 (6): 2514–2522.
https://doi.org/10.1158/0008-5472.CAN-08-4709
Published: 17 March 2009
View article titled, The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Open the PDF for The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies in another window
Journal Articles

A novel role of tyrosine kinase inhibitor in the reversal of immune tolerance and modulation of the tumor microenvironment in immune-based therapies

Junko Ozao, Ge Ma, Celia Divino, George Wang, Ping-Ying Pan, Shu-Hsia Chen
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4892.
Published: 01 May 2008
View article titled, A novel role of tyrosine kinase inhibitor in the reversal of immune tolerance and modulation of the tumor microenvironment in immune-based therapies
Journal Articles

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

Bo Huang, Ping-Ying Pan, Qingsheng Li, Alice I. Sato, David E. Levy, Jonathan Bromberg, Celia M. Divino, Shu-Hsia Chen
Journal: Cancer Research
Cancer Res (2006) 66 (2): 1123–1131.
https://doi.org/10.1158/0008-5472.CAN-05-1299
Published: 19 January 2006
View article titled, Gr-1<sup>+</sup>CD115<sup>+</sup> Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host
Open the PDF for Gr-1<sup>+</sup>CD115<sup>+</sup> Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host in another window
Journal Articles

Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity

Qingsheng Li, Ping-Ying Pan, Peidi Gu, Dongping Xu, Shu-Hsia Chen
Journal: Cancer Research
Cancer Res (2004) 64 (3): 1130–1139.
https://doi.org/10.1158/0008-5472.CAN-03-1715
Published: 10 February 2004
View article titled, Role of Immature Myeloid Gr-1<sup>+</sup> Cells in the Development of Antitumor Immunity
Open the PDF for Role of Immature Myeloid Gr-1<sup>+</sup> Cells in the Development of Antitumor Immunity in another window